Apoptotic pathways of epothilone BMS 310705

By Uyar D.   Takigawa N.   Mekhail T.   Grabowski D.   Markman M.   Lee F.   Canetta R.   Peck R.   Bukowski R.   Ganapathi R.  

Gynecologic Oncology, Vol. 91, Iss. 1, 2003-10 ,pp. : 173-178

Elsevier

Access to resources Recommend Favorite

Recurrent Invasive Adenocarcinoma after Hysterectomy for Cervical Adenocarcinoma in Situ

By Krivak T.C.   Retherford B.   Voskuil S.   Rose G.S.   Alagoz T.  

Gynecologic Oncology, Vol. 77, Iss. 2, 2000-05 ,pp. : 334-335

Elsevier

Access to resources Recommend Favorite

Treatment of Recurrent Adenocarcinoma of the Endometrium with Pelvic Exenteration

By Morris M.   Alvarez R.D.   Kinney W.K.   Wilson T.O.  

Gynecologic Oncology, Vol. 60, Iss. 2, 1996-02 ,pp. : 288-291

Academic Press

Access to resources Recommend Favorite

New drugs in the treatment of recurrent or metastatic cervical cancer

By Savarese A.   Cognetti F.  

Critical Reviews in Oncology/Hematology, Vol. 48, Iss. 3, 2003-12 ,pp. : 323-327

Elsevier

Access to resources Recommend Favorite

Is the Invasion Depth in Millimeters Valid to Determine the Prognosis of Early Invasive Cervical Adenocarcinoma?: A Case of Recurrent FIGO Stage IA1 Cervical Adenocarcinoma

By Utsugi K.   Shimizu Y.   Akiyama F.   Hasumi K.  

Gynecologic Oncology, Vol. 82, Iss. 1, 2001-07 ,pp. : 205-207

Elsevier

Access to resources Recommend Favorite